Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKore Potash PLC Regulatory News (KP2)

Share Price Information for Kore Potash PLC (KP2)

Share Price is delayed by 15 minutes
Get Live Data
3.05    0.07 (2.35%)
Bid:
2.90
Ask:
3.20
Spread: 0.30 (10.345%)
Market Cap: £157.87m
KP2 Live PriceLast checked at - London Stock Exchange

Intraday Kore Potash PLC Share Chart

Total Voting Rights

29 Dec 2023 07:00

RNS Number : 8351X
Kore Potash PLC
29 December 2023
Ā 

29 December 2023

Kore Potash Plc

("Kore Potash" or the "Company")

Total Voting Rights

Kore Potash plc announces, for the purposes of the FCA's Disclosure and Transparency Rules, that the total issued share capital of the Company consists ofĀ 4,119,667,120 ordinary shares of US$0.001 each with voting rights.

The total number of voting rights in the Company isĀ 4,119,667,120 and this figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in the interest in, the share capital of the Company.

This announcement has been approved for release by the Board.

For further information, please visitĀ www.korepotash.comĀ or contact:

Ā 

Kore Potash

David Hathorn - Chairman

Tel: +27Ā 84 603 6238

Tavistock Communications

Nick Elwes

Adam Baynes

Tel: +44 (0) 20 7920 3150

SP Angel Corporate Finance -Ā Nomad and Joint Broker

Ewan Leggat

Charlie Bouverat

Tel: +44 (0) 20 7470 0470

Shore CapitalĀ - Joint Broker

Toby Gibbs

James Thomas

Tel: +44 (0) 20 7408 4050

Questco Corporate AdvisoryĀ - JSE Sponsor

DonƩ Hattingh

Tel: +27 (11) 011 9205

Ā 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Ā 
END
Ā 
Ā 
TVRFLFSSFALFFIV
Date   Source Headline
1st May 20258:00 amRNSStatement re. Suspension
30th Apr 20257:00 amRNSReview of Operations - Quarter ended 31 March 2025
29th Apr 202512:51 pmRNSTrading Halt
28th Apr 20253:23 pmRNSDraft non-binding financing Term Sheet received
22nd Apr 20257:00 amRNSConditional Grant of Options
4th Apr 20257:00 amRNSCDI Monthly Movement
2nd Apr 20257:15 amRNSResults of shareholders analysis
2nd Apr 20257:15 amRNSNotification of Major Shareholding
2nd Apr 20257:00 amRNSFundraise of US$10.6m – Chairman’s participation
1st Apr 20252:34 pmRNSKola Financing Term Sheet Update
31st Mar 20257:00 amRNSFinancial Results for Year Ended 31 December 2024
25th Mar 20257:00 amRNSExtension of Cleansing Prospectus Offer Period
21st Mar 20252:07 pmRNSFundraise to raise approximately US$10.6 million
6th Mar 20257:00 amRNSCDI Monthly Movement
27th Feb 20258:44 amRNSConfirmation of mineral resource for Kola Deposit
27th Feb 20258:43 amRNSKola Project Optimised DFS update
5th Feb 20257:00 amRNSCDI Monthly Movement
30th Jan 20257:30 amRNSExtension of Cleansing Prospectus Offer Period
30th Jan 20257:00 amRNSReview of Operations for Quarter ended 31 Dec 2024
20th Jan 20259:37 amRNSResults of shareholders analysis
7th Jan 20257:00 amRNSCDI Monthly Movement
6th Dec 20247:00 amRNSCDI Monthly Movement
27th Nov 202410:49 amRNSResponse to ASX Aware Letter
22nd Nov 20247:00 amRNSLodgement of Cleansing Prospectus
20th Nov 20247:00 amRNSFinalisation of EPC Contract
11th Nov 20241:49 pmRNSTrading Halt, Amended Admission,Fundraising Update
7th Nov 20249:37 amRNSTrading Halt, & Amended Admission Date
5th Nov 202411:29 amRNSAnnouncement of Fundraise
5th Nov 20247:00 amRNSCDI Monthly Movement
31st Oct 20247:00 amRNSReview of Operations for Quarter to 30 Sept 2024
4th Oct 20247:00 amRNSCDI Monthly Movement
13th Sep 20247:00 amRNSFinancial Results for Half Year Ended 30 June 2024
4th Sep 20247:00 amRNSCDI Monthly Movement
23rd Aug 20242:00 pmRNSResults of General Meeting
6th Aug 20247:00 amRNSCDI Monthly Movement
31st Jul 20247:00 amRNSReview of Operations for Quarter to 30 June 2024
23rd Jul 20247:00 amRNSNotice of GM
3rd Jul 20247:00 amRNSCDI Monthly Movement
1st Jul 20249:30 amRNSFundraise of US$1,281,000
27th Jun 20247:00 amRNSAppointment of Non-Executive Director
24th Jun 20249:15 amRNSEPC Update
6th Jun 202411:15 amRNSResult of AGM
5th Jun 20247:00 amRNSCDI Monthly Movement
4th Jun 20247:00 amRNSRemote Access to AGM
23rd May 202411:06 amRNSResponse to ASX price and volume query
14th May 20249:00 amRNSResults of General Meeting & Issue of Shares
14th May 20247:00 amRNSCommencement of Trading on A2X Exchange
8th May 20247:00 amRNSCDI Monthly Movement
7th May 20247:00 amRNSSecondary Listing on A2X Exchange
3rd May 20247:00 amRNSNotice of 2024 AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.